Related by context. All words. (Click for frequent words.) 74 See WARNINGS 73 Full Prescribing Information 72 full Prescribing Information 71 Boxed Warning 70 FULL PRESCRIBING INFORMATION 70 Prescribing Information 69 Boxed Warnings 69 boxed WARNING 68 Contraindications 68 including boxed WARNINGS 67 See CLINICAL PHARMACOLOGY 67 www.sanofi aventis.us 66 FDA APPROVES 66 TREATMENT OF 65 IN PATIENTS WITH 65 Complicated Skin 64 CENTERS FOR DISEASE CONTROL 64 visit www.sanofi aventis.us 64 www.sanofi aventis.com 63 Boxed WARNINGS 63 IN COMBINATION WITH 63 TO AVOID PREGNANCY WHILE 63 CLINICAL TRIALS 63 PLEASE VISIT 63 Product Monograph 63 Package Insert 63 Soriatane 63 REPRONEX R menotropins 63 REPRONEX ® menotropins 62 Advanced Melanoma 62 pan histone deacetylase 62 Orally Disintegrating Tablets 62 abacavir sulfate lamivudine 62 Submits NDA 62 THERAPY FOR 62 Medication Guide 62 WHEN YOU CAN DO 62 Phase 2b Study 62 THAT ARE DIFFICULT TO 62 Adjunctive Therapy 62 Refractory Hodgkin Lymphoma 61 visit www.LifeVantage.com 61 DISORDERS 61 FOR ADDITIONAL 61 CARDIOVASCULAR 61 R rosiglitazone maleate 61 Phase IIb Trial 61 Diabetic Neuropathy 61 PSORIASIS 61 AMMONUL R 61 AND PREVENTION 61 Expanded Indication 61 Mg Usa 61 www.sanofipasteur.us 61 R lenalidomide 61 RECEIPT OF 61 IS REQUIRED 61 Dexilant 61 VISICOL R 61 FROM THE COMPANY 61 SHOULD CONTACT 61 5q MDS 60 Initiate Clinical Trial 60 ID NCT# 60 IN NATURE 60 DESIGNED TO 60 Hepatic Encephalopathy 60 #mg Tablets [002] 60 colesevelam HCl 60 Ranolazine 60 Phase IIa Clinical Trial 60 J Am Coll 60 Kuvan TM sapropterin 60 TO REQUEST 60 ARE PROVIDED AS IS 60 uricase 60 sapropterin dihydrochloride 60 refractory chronic lymphocytic 60 visit http:/www.ininc.us 60 injection USP 60 Phase 2b Clinical Trial 60 ® chorionic gonadotropin 60 LENALIDOMIDE 60 PROMACTA CARES 60 OR CONTENT CONTAINED THEREIN 60 metastatic malignant 60 Anecdotal yodel.yahoo.com 59 Placebo Controlled Trial 59 call #.#.NEXAVAR #.#.#.# 59 CYP#A# CYP#D# 59 LibiGel ® 59 Emtriva Viread 59 www.flutest.com 59 info@endeca.com 59 PET FROM 59 STUDY RESULTS 59 Hormone Refractory Prostate Cancer 59 Fondaparinux 59 COLLABORATION WITH 59 myocardial infarction ventricular fibrillation 59 VIVITROL ® 59 www.fda.gov medwatch 59 Metformin HCl 59 Nexavar prescribing 59 Acute Treatment 59 propafenone 59 email info@sunrisetelecom.com 59 TO REGISTER 59 Clinical Trial Evaluating 59 Elagolix 59 MedWatch website 59 balsalazide disodium Capsules 59 samarium Sm 59 ABOUT YOUR JOB 59 TOPROL XL 59 www.artesmedical.com 59 please visit www.arbinet.com 59 Oral Fingolimod 59 LEARN MORE ABOUT 58 Adjuvant Chemotherapy 58 COMPLAINTS ABOUT 58 Patients Treated With 58 Severe Sepsis 58 NDA Submission 58 Product Characteristics 58 Pharmacokinetics PK 58 BY CALLING TOLL FREE 58 sodium benzoate prescription 58 TOOL FOR 58 MAY PRODUCE 58 Prilosec omeprazole 58 www.niddk.nih.gov 58 Orthop Surg 58 PROCRIT R 58 PROCRIT 58 PENTASA 58 THE ORLANDO FLA. 58 Adjuvant Treatment 58 Schizophrenia Treatment 58 FUTURE EVENTS 58 visit www.quidel.com www.colorectal 58 AERIUS 58 Plaque Psoriasis 58 DIAGNOSTIC 58 Novel Oral 58 TO EDUCATE 58 Cardiol 58 PRN1 58 Hydrochlorothiazide Tablets 58 vapreotide acetate 58 Maven Semantic 58 BUPHENYL R 58 Study Evaluating 58 NestleNewsroom.com 58 Controlled Trial 58 www.artefill.com 58 XYNTHA 58 ethinyl estradiol tablets 58 visit www.globalrailway.com 58 Calcium Acetate 58 Prospective Randomized 58 hypereosinophilic syndrome 58 Demonstrates Significant 58 Trobalt 58 Extended Release 58 Receives Orphan Drug Designation 58 Vaccine Adjuvant 58 BenzaClin 58 KEFLEX 58 THERAPY AND 58 Phase 2b Trial 58 visit smith.com 58 myelodysplastic myeloproliferative diseases 58 Ovidrel 58 Catheter Associated 58 BY CALLING 58 SinoFresh TM 58 Receives Approvable Letter 58 aripiprazole Abilify 57 Drug Eluting Stent System 57 Meets Primary Endpoint 57 LUPUS 57 Submits Supplemental 57 hydrochloride tablets 57 TO IDENTIFY 57 RECOMMENDED FOR 57 www.windhover.com 57 ABILIFY ® 57 www.soliris.net 57 Patient Enrollment 57 Demonstrates Positive 57 Pooled Analysis 57 TO PREDICT 57 visit www.dobimedical.com 57 Valopicitabine 57 Advanced Renal Cell 57 Hepatotoxicity 57 Combination REOLYSIN R 57 ADDRESS AND 57 PHASE III 57 THE STUDY 57 Antitumor Activity 57 TOPAMAX R 57 Protease Inhibitor 57 Announces Tentative Approval 57 EMSAM 57 AND RECOMMENDATIONS 57 www.capitalsbdc.umd.edu 57 ANDA Filing 57 Generic Version 57 metformin HCl 57 #-# teletypewriter 57 acetonide FA 57 Relapsing Multiple Sclerosis 57 http:/news.xerox.com 57 www.connectyx.com 57 Hormone Receptor Positive 57 OR BY CALLING 57 mrosenberg@freepress.com 57 Teva Provides Update 57 octreotide acetate 57 TRELSTAR R 57 TO PATIENTS 57 news subscribe.htm 57 Raptiva R 56 STUDIES AND 56 REWARDS FOR 56 number NCT# ClinicalTrials.gov 56 Venous Thromboembolism 56 Cellceutix web 56 Secondary Hyperparathyroidism 56 FACTIVE R gemifloxacin 56 ILLNESSES 56 http:/www.cyberonics.com 56 PLEASE READ THE FOLLOWING 56 Files IND 56 Chronic Heart Failure 56 www.udetection.com 56 CIMZIA TM certolizumab pegol 56 Acute Myocardial Infarction 56 ALN HPN 56 Tyrosine Kinase Inhibitor 56 Phase III Clinical Trial 56 Diabetic Nephropathy 56 HyperIP visit www.netex.com 56 STENT 56 EXALGO 56 X# HER SISTER 56 OTHER DOCUMENTS 56 Granted Orphan Drug 56 sorafenib tablets 56 contact Tom Ehart 56 regarding Daxor Corporation 56 www.allos.com 56 Soft Tissue Sarcoma 56 PUBLISHED IN 56 visit www.surgicountmedical.com 56 ferumoxytol Injection 56 Prevacid ® 56 THERAPEUTICS 56 www.cancer.gov 56 Pivotal Phase III 56 RESTYLANE R 56 Phase 2a Trial 56 RELEVANCE 56 Regenerative Cells 56 Confirmatory Phase 56 malbom@freepress.com 56 Recurrent Glioblastoma 56 AMEX NVD visit 56 REVENGE FOR 56 Free Full Text 56 www.gsk.com 56 PREVAIL 56 Oral Suspension #mg 56 SANVAR 56 Visit Adeptron 56 First Patient Enrolled 56 RIP CURRENTS ARE 56 THE IMPLEMENTATION OF 56 FIRST QUARTER FINANCIAL RESULTS 56 O# Essential Oil 56 YOUR LOCAL ANIMAL SHELTER 56 Initiates Clinical Trial 56 Supplemental Biologics License Application 56 Aldactone 56 visit www.communitybankna.com 56 PDX pralatrexate 56 www.mgipharma.com 56 HOLLYWOOD POWER BROKERS 56 Completes Enrollment 56 www.nymox.com email info@nymox.com 56 mGluR5 negative 56 Randomized Double blind 56 http:/www.diabetes.org 56 Peripheral Arterial 56 pressroom pressroom.yahoo.com 56 Generic Versions 56 msiceloff@marlerclark.com 56 MODIFICATION OF 56 OUR OFFICES AT 56 II Clinical Trial 56 J Am Acad 56 information visit www.i2telecom.com 56 Acute Ischemic Stroke 56 Prolongs Survival 56 Medicis prescription 56 call #-#-CAPELLA #-# 56 http:/www.cephalon.com/ 56 Autologous Stem Cell Transplantation 55 NUEDEXTA ™ 55 WHO TOOK 55 DOCUMENTS BECAUSE THEY CONTAIN 55 Generic Version Of 55 Losartan Potassium 55 www.roche 55 www.charlesandcolvard.com 55 OR VISIT 55 PRECISE 55 www.uroplasty.com 55 pave@globe.com 55 Oral Solution 55 Phase Ib Clinical Trial 55 Embolic Protection Device 55 information visit Nestleusa.com 55 J Allergy Clin 55 ULTRASE 55 http:/www.clinicaltrials.gov 55 lgriffy@mercurynews.com 55 inhalation aerosol 55 Phase IIb Clinical Trial 55 Pharmacokinetic Study 55 www.cellceutix.com 55 ABLYNX 55 Aplidin R 55 METOZOLV 55 COLAZAL R 55 Metastatic Melanoma 55 www.endeca.com 55 Visit www.qsii.com 55 Therapy Evaluation 55 website www.iteknik.com 55 Phase III Pivotal 55 call #-#-CALL-HOME 55 talk.html 55 INFO ON 55 bsnavely@freepress.com 55 lexidronam injection 55 Pafuramidine 55 metastatic GIST 55 FOLOTYN ® 55 www.med 55 PUBLISHED ON 55 Completes Patient Enrollment 55 acid reducer 55 Phase III Trial 55 Loxapine 55 Am J Obstet 55 #-# Full Text 55 Acular 55 cisplatin gemcitabine 55 http:/www.bms.com 55 please visit www.toyota.co.jp 55 fda.gov 55 Pivotal Trial 55 dependent kinase inhibitor 55 www.HirschElectronics.com 55 TRANSFORMS 55 Diastat 55 PATENT FOR 55 Clinical Trial Results 55 information visit www.axa 55 2 NATROL #-#-#-# 55 = document.location.protocol 55 WEB OF SCIENCE 55 Clinical Trial Data 55 Unstable Angina 55 Chronic HCV 55 www.voicestick.com 55 ENTRY INTO 55 TLK# 55 Ranexa R 55 CYT# potent vascular disrupting 55 DNA methyltransferase inhibitors 55 XAGRID 55 HuCAL GOLD R 55 visit http:/www.scolr.com/ 55 biosciences.com 55 Investigational Device 55 IL# PE#QQR 55 please visit www.anci 55 PROTEGE 55 GENERIC SILDENAFIL SOFT Generic 55 INITIATE 55 oritavancin semi 55 e mail info@cuttingedgeinfo.com 55 Intravascular 54 Besivance 54 pharma.com 54 Carotid 54 Phase IIIb 54 http:/www.JazzPharmaceuticals.com 54 please visit www.kyocera 54 Veronate R 54 IND Filing 54 toenail onychomycosis 54 Polymerase Inhibitor 54 Dose Ranging Study 54 Trial Evaluating 54 PDUFA Date 54 #mg capsules [002] 54 Feraheme ® 54 DURAGESIC 54 doi #.#/fj.#-# 54 Antigen Express website 54 DEADLINE TO 54 mg Tablets 54 'S NOT PREGNANT 54 Clostridium difficile Infection 54 INFORMATION SYSTEMS 54 PRN8 54 Tumor Response 54 Contact MICHAEL ROSENBERG 54 Efudex 54 Veregen TM 54 Contact BRENT SNAVELY 54 Shows Promise Against 54 MAGE A3 ASCI 54 var gaJsHost = https 54 Initiates Enrollment 54 visit http:/www.entrust.com 54 www.syntapharma.com 54 balsalazide tablet 54 PROVENGE ® 54 information visit www.mda.gov.sg 54 TREATMENT OPTIONS 54 www.boehringer ingelheim.com 54 Methylin 54 FIRMAGON 54 novel VDA molecule 54 TRISENOX ® 54 J Pediatr 54 Arzerra TM 54 Diabetic Foot Ulcer 54 www.cmdiagnostics.com 54 REPORTS RECORD 54 Contact MITCH ALBOM 54 Brentuximab Vedotin SGN 54 dbirkett@freepress.com 54 www.solosendoscopy.com 54 Achieves Primary Endpoint 54 Antiviral Activity 54 metastatic neuroendocrine tumors 54 medical.com 54 Abstract Full Text 54 Prodarsan R 54 By JENNIFER LEARN 54 Generic Viagra Soft Tabs 54 visit www.gsk.com 54 FROM THE OPINIONJOURNAL 54 www.vioquestpharm.com 54 Daytrana ® 54 Hepatocellular Carcinoma 54 NANOTECH 54 Zyflo CR 54 Child Adolesc Psychiatry 54 Abstract Free Full Text 54 Systemic Sclerosis 54 www.vivus.com 54 e mail entrust@entrust.com 54 Initiates Phase II 54 please visit www.advaxis.com 54 www.sorin.com 54 HOTLINE AT #-#-#-# TTY 54 Clinical Outcome 54 dsharp@freepress.com 54 CONCERTA R 54 SCOLR Pharma please 54 Demonstrates Sustained 54 Fortical R 54 www.essure.com 54 Skin Lesions 54 Presents Preclinical Data 54 www.bdal.com 54 Psychopharmacol 54 Chronic Hepatitis C 54 reporter Mike Blasky 54 Pivotal Phase 54 www.sedonacorp.com 54 Dermatol 54 call Oveda Slade 54 kidney urologic 54 www.nupathe.com 54 YEAR END RESULTS CONFERENCE 54 Visit CompuMed 54 Fougera 54 www.crtx.com 54 Epivir HBV R 53 Visicol 53 Twinject ® 53 2 inhibitor CYT# 53 http:/www.cytogen.com 53 Clinical Evaluation 53 TELCYTA 53 call #.#.CAPELLA #.# 53 OMNARIS 53 Carbidopa Levodopa 53 visit http www.cpsc.gov 53 Initiates Phase 2b 53 Achillion Pharmaceuticals please 53 Naglazyme R galsulfase 53 HDAC Inhibitor 53 Soft Tabs 53 Naive Patients 53 www.novartis.com 53 http:/www.chips.toshiba.com 53 Randomized Evaluation 53 visit www.abiresearch.com 53 pralatrexate injection folate analogue 53 ANN INTERN MED 53 Tablets #mg [002] 53 http:/www.prnewswire.com/broadcast/#/consumerCrexendo Business 53 Medullary Thyroid Cancer 53 Zolpimist 53 Cozaar ® 53 call +#.#.#.# +#.#.#.# 53 www.compumed.net 53 www.cardiome.com 53 www.nature.com 53 Phase 1b Clinical Trial 53 tazarotene 53 www.medtechinsight.com 53 visit www.skincancer.org 53 ASTEROID 53 Dose Response 53 Miacalcin 53 FURTHER DETAILS 53 Clinicaltrials.gov 53 AMX NVD visit 53 Generic Levitra Vardenafil 53 www.durect.com 53 CrossRef Medline 53 rALLy 53 newsmakers@phillynews.com 53 bazedoxifene conjugated estrogens 53 contact Mary Siceloff 53 Marketed Products 53 Pivotal Study 53 coverage Boxed Facial 53 www.alexionpharma.com 53 Impax generic 53 DDAVP 53 fosbretabulin 53 www.avigen.com 53 Randomized Controlled Trials 53 Surgical Treatment 53 Oral Jelly 53 www.novadel.com 53 tehart@marketresearch.com 53 information visit www.xactlycorp.com 53 www.pranabio.com 53 www.adeptron.com 53 Anticancer Programs section 53 Tenormin 53 Nephrol 53 Wintergreen Resort STAY 53 www.questcor.com 53 REBETOL combination therapy 53 www.middlebrookpharma.com 53 Orapred ODT 53 www.protandim.com 53 Auto Injector 53 Contact DAVE BIRKETT 53 http:/www.atherogenics.com 53 SPL# Gel vaginal microbicide 53 Randomized Double Blind 53 Sipuleucel T 53 Initiates Phase III 53 call +#-#- SABA 53 www.aryx.com 53 www.achillion.com 53 identifier NCT# 52 www.opexatherapeutics.com 52 information Wendy Keyzer 52 Katherine Dibling 52 visit www.Natrol.com 52 TO INITIATE 52 Investigational Drug 52 NetEx NetEx IP 52 ZANAFLEX 52 Percutaneous Tibial Nerve Stimulation 52 misspelling email programming@wclo.com 52 PRIZE FOR 52 REC Solar visit www.recsolar.com 52 e mail acantatore@turlockjournal.com 52 www.bms.com 52 ANNOUNCES PARTNERSHIP WITH 52 CAN ACTUALLY 52 MATERIALS AND 52 http:/www.beaufortfiredept.com 52 Cell Lymphoma 52 Company website http:/www.shire.com 52 Preclinical Data 52 Urea Cycle Disorder 52 Tanespimycin 52 Visit www.fda.gov medwatch 52 www.coade.com 52 SCM Microsystems web 52 Telik logo TELINTRA 52 Cancer Incidence Mortality 52 http:/www.fda.gov 52 CARDS AND 52 endometriosis ovarian cysts 52 SHEDS LIGHT ON 52 AAG geldanamycin analog 52 Observational Study 52 PHASE II 52 Triapine R 52 Morphine Sulfate 52 Meta Analysis 52 visit www.icadmed.com 52 Hedgehog Pathway Inhibitor 52 http:/www.gpc-biotech.com 52 STRATEGY FOR AN OPEN 52 www.aidshealth.org 52 www.ses newskies.com 52 Augment ™ 52 galiximab 52 Bruton tyrosine kinase 52 metoprolol succinate 52 RevAssist R 52 Sumatriptan Succinate 52 visit http:/www.fda.gov 52 AVAILABLE THROUGH 52 Swiss Medica flagship 52 www.labopharm.com 52 MERLIN TIMI 52 Dose Escalation 52 http:/www.captaris.com 52 Phase III multicenter 52 Patient Registry 52 www.utimaco.com 52 Receives Orphan Drug 52 visit http:/www.sunesis.com 52 Bone Metastases 52 +#-#- 52 Obstet Gynecol 52 www.resverlogix.com 52 hydrochloride extended 52 Randomized Phase 52 PHARM 52 www.novadaq.com 52 By JAMAAL ABDUL 52 Randomized Controlled 52 Antigen Specific 52 First Patient Treated 52 www.myglobaltalk.com 52 iCADnow 52 -#-# Fax +1- 52 PRESENTED AT 52 biliary tract cancer 52 ZEGERID Powder 52 http:/www.palatin.com 52 Arch Pediatr Adolesc Med 52 #mg #mg [002] 52 ThermoDox ® clinical 52 Randomized Clinical Trial 52 Left Ventricular Dysfunction 52 http:/www.cticseattle.com 52 Please visit www.ntt.com 52 www.adeonapharma.com 52 CORD BLOOD 52 WEATHER CALL 52 visit www.mssociety.ca 52 logging onto www.gtc 52 Randomized Phase II 52 www.thepopcornfactory.com 52 www.clinicaltrials.gov 52 Randomized Double Blind Placebo 52 Late Breaker 52 Entereg R 52 Emerging Therapies 52 www.cerus.com 52 Topics Covered I. INTRODUCTION 52 ID Seq 52 SARNECKI 52 ENTEREG ® 52 Viagra Soft 52 Proc Am Soc 52 Xelox 52 www.anthera.com 52 Injection USP 52 Computed Tomographic 52 visit www.dlt.com 52 Ralivia TM 52 www.avatech.com 52 information visit www.consona.com 52 Vascugel ® 52 crizotinib PF # 52 treatment naive genotype 52 Julie Garand 52 http:/www.clinicaltrials.gov/ 52 Formore information 51 recurrent metastatic ovarian cancer 51 retinal vein occlusion induced 51 www.biodeliverysciences.com 51 #:#-# [023] 51 ir@crucell.com www.crucell.com 51 Lamictal ODT 51 DIRECT Trial 51 MKC# MKC# PP 51 #:# -# [003] 51 #:#-# [033] 51 Sodium Injection 51 email info@eplus.com 51 RAZADYNE 51 PrandiMet 51 multicenter Phase III 51 please visit www.tropos.com 51 email contact@sugarcrm.com 51 Generic Cialis Soft Tabs 51 Presents Positive 51 MetaDrug TM 51 www.itmag.com 51 non nucleoside inhibitor 51 SYCREST 51 Visit www.lxe.com 51 phase IIIb 51 Int J Radiat Oncol 51 NCT# 51 www.advaxis.com 51 PUBMED 51 Visit www.unify.com 51 www.chembio.com 51 visit http:/www.electronicrecyclers.com 51 visit www.amrb.com 51 Contact CARLOS MONARREZ 51 ONCOLOGY 51 visit www.msf usa.org 51 Abacavir Sulfate 51 venlafaxine hydrochloride 51 Double Blind Placebo 51 www.austriamicrosystems.com 51 Xenazine ® 51 visit http:/www.sugarcrm.com 51 Vascular Disrupting Agent 51 insights.com 51 Nat Genet 51 SUMAVEL 51 Presents Preclinical 51 please visit http:/www.toshiba.com/taec/ 51 Zenvia Phase III 51 Syndr 51 www.rosettabio.com 51 polycythemia vera essential thrombocythemia 51 worsening thrombocytopenia 51 http:/www.cephalon.com 51 VEHICLE SAFETY HOTLINE AT 51 Initiate Phase 51 www.web.com 51 www.ClinicalTrials.gov 51 www.accellent.com 51 www.identive group.com 51 Oxandrin R 51 www.baxa.com 51 Antiviral Therapy 51 Arch Neurol 51 paroxetine hydrochloride 51 Bupropion HCl ER 51 5mg #mg #mg 51 http:/www.curagen.com 51 www.cticseattle.com 51 ReFacto 51 INITIATES 51 Cochrane Database Syst Rev 51 Fluticasone Propionate 51 Stent Implantation 51 hyaluronidase enzyme 51 Daytrana ™ 51 Genasense ® oblimersen 51 www.xzeres.com 51 tommy.deas @ tuscaloosanews.com 51 Ucyclyd Pharma Inc. 51 please visit www.learn.com 51 www.paintrials.com 51 #-#-DIABETES 51 www.gene.com 51 http:/www.immtechpharma.com 51 www.tranzyme.com 51 http:/www.gsk.com 51 IMPACT DCM 51 Prospective Multicenter 51 visit www.thechaplain.net 51 www.orasure.com 51 www.vical.com 51 please visit www.actify.com 51 SABCS 51 ANALYST E MAIL 51 QuadraSphere 51 www.celsion.com 51 please visit www.middlebrookpharma.com 51 lenalidomide Revlimid R 51 www.amarincorp.com 51 Reach Tommy Deas 51 www.geovax.com 51 investor@norsat.com 51 Dostinex 51 jprzybys@reviewjournal.com 51 www.flukenetworks.com 51 http:/www.idenix.com 51 XL# anticancer compounds 51 SANTE 51 Contact Jomay Steen 51 Acute Decompensated Heart Failure 51 Initiates Clinical 51 Expedited Review 51 Psychiatry Clin Neurosci 51 Refractory Angina 51 clopidogrel bisulfate 51 Testosterone MDTS R 51 www.active 51 www.pgxhealth.com 51 www.criticaloutcome.com 51 Services #:#-#,# Abstract 51 Ronald H. Spair 51 Contact Marvin Pave 51 Xyntha 51 Parathyroid Hormone 51 Arch Otolaryngol Head 51 nasal calcitonin product 51 intravesical infusion therapy 51 brands RESTYLANE R 51 www.obagi.com 51 TECHNOLOGIST 51 http:/www.durect.com 51 RIBBON 51 www.caliperLS.com 51 Endocrinol Metab 51 Arch Intern Med 51 Patient Enrolment 51 Topline Results 51 Prostate AdenoCarcinoma Treatment 50 http:/www.hematology.org 50 GATTEX ™ 50 HDAC Inhibitors 50 Testosterone MDTS ® 50 Reach Drew Voros 50 VASCULAR 50 J Am Soc 50 Application MAA 50 Reports Preclinical Data 50 ANNOUNCES LAUNCH OF 50 www.regenerx.com 50 Call CareCall #-#-# 50 www.feedroom.com 50 ACUROX 50 www.immuneregen.com 50 visit http:/www.dollargeneral.com 50 Eur J Endocrinol 50 solifenacin succinate 50 med.com 50 mertansine 50 PrevOnco 50 phase IIb study 50 Renal Cell Carcinoma RCC 50 FASEB J. 50 dan.bickley @ arizonarepublic.com 50 Suppl. 50 www.osteologix.com 50 visit www.agile.com 50 Noroxin 50 Environ Health Perspect 50 Duragesic patches sold 50 Oscient promotes ANTARA 50 www.shire.com 50 CD# [004] 50 www.crucell.com 50 NOTE TO FIRST TIME 50 please visit www.vocus.com 50 #-#-# x# [002] 50 registrational Phase 50 LREIT please 50 www.synchronica.com 50 visit www.r calfusa.com 50 visit http:/www.thinkhdi.com 50 MIVI III 50 multicenter multinational 50 please email lparadis@platinex.com 50 acyclovir Lauriad R 50 www.ecri.org 50 Risperidone Oral Solution 50 Oiye Guerrant Associates 50 First Aid Antiseptic 50 Risk Stratification 50 www.ziopharm.com 50 pancrelipase 50 Levocetirizine 50 GENENTECH 50 doi #.# 50 http:/www.celgene.com 50 J Acquir Immune Defic 50 http:/www.pharmacopeia.com 50 Multiple Ascending Dose 50 mblasky@reviewjournal.com 50 visit http:/www.stillsecure.com 50 SUPERVILLE 50 hyaluronic acid PERLANE R 50 Matrix Phase 2b 50 Abbott Laboratories Depakote 50 candidates Augment ™ 50 sitagliptin phosphate 50 esharp@freepress.com 50 ExTRACT TIMI 50 http:/www.scmmicro.com 50 subsidiary Kidz Med 50 http:/www.marinabio.com 50 MBRX 50 www.neurogesx.com 50 evaluating carfilzomib 50 www.malbex.ca 50 www.delcath.com 50 R roscovitine 50 msnyder@freepress.com 50 TO REINFORCE 50 visit www.entrust.com 50 info@tropos.com 50 e mail sstafford@turlockjournal.com 50 AND METHODS 50 www.anci care.com 50 suppl. 50 www.ilgenetics.com 50 Contact Newsmakers 50 Vivancos File 50 visit www.cmhc.ca 50 www.xrite.com 50 Kinase Inhibitor 50 #.#mg #mg 50 Hepatocellular Carcinoma HCC 50 www.transcept.com 50 www.lonza.com 50 www.medline.com 50 Stavzor 50 visit www.silvercross.org 50 Clinical Practice Guideline 50 programs visit http:/www.bionovo.com 50 www.cellgenesys.com 50 www.vyteris.com 50 www.walgreens.com 50 Current Controlled Trials 50 clinicaltrials 50 www.candelalaser.com 50 PD2i CA 50 e mail info@verichipcorp.com 50 Vena Resources please 50 http:/www.baxa.com 50 PANVAC VF 50 Contact Suzanne Ulbrich 50 www.schering plough.com 50 visit TheClassicalStation.Org 50 www.telik.com 50 visit http:/www.logility.com 50 http:/www.alexza.com 50 www.xoma.com 50 www.stevens.edu 50 PROVIGIL R 50 Therapeutic Competitors companiesandmarkets.com adEgemonye 50 TASKi2 50 TriMix gel TM 50 visit www.psoriasis.org 50 hob.com sandiego 50 www.digirad.com 50 www.kmbs.konicaminolta.us 50 www.rand.com 49 visit www.unotron.com 49 FreeWave directly 49 Initiate Phase II 49 visit www.unigene.com 49 please visit www.intacct.com 49 http:/www.national.com 49 Verathon Medical 49 visit www.spirecorp.com 49 www.bio rad.com 49 Decompensated Heart Failure 49 Kosan Biosciences please 49 contact KUKA Robotics 49 visiting www.wyndham.com 49 #-#-REDCHIP #-# Ext 49 BOX BELOW 49 Ambulatory Blood Pressure 49 IOVS 49 MGd 49 information visit http:/www.bit9.com 49 @ novartis.com 49 #:# -# [004] 49 Randomized Trials 49 Cloretazine 49 Dr. Saeid Babaei 49 Oral Suspension 49 www.interscience.wiley.com